Stay updated on Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe ClinicalTrials.gov page now displays the NICARAGUA trial record, including its study design, eligibility criteria, locations, outcome measures, and completed status, instead of a 403 error page.SummaryDifference55%

- Check14 days agoChange DetectedThe site footer’s displayed revision changes from v3.7.2 to v3.8.0, while the study record remains unavailable.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide notice announces an NIH website transition and says some content will use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference1%

- Check28 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check56 days agoChange DetectedAccess to the NICARAGUA study record now shows a 403 Forbidden error, replacing the study details with an access-denied message.SummaryDifference19%

Stay in the know with updates to Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page.